COR vs. MCK, CAH, HSIC, PDCO, OMI, HLF, NUS, PETQ, HWH, and BIMI
Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), HWH International (HWH), and BIMI (BIMI).
McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.
McKesson has higher revenue and earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.
McKesson has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500.
McKesson currently has a consensus target price of $571.47, indicating a potential upside of 0.33%. Cencora has a consensus target price of $233.90, indicating a potential upside of 3.24%. Given McKesson's higher possible upside, analysts clearly believe Cencora is more favorable than McKesson.
In the previous week, McKesson had 22 more articles in the media than Cencora. MarketBeat recorded 36 mentions for McKesson and 14 mentions for Cencora. Cencora's average media sentiment score of 0.57 beat McKesson's score of 0.25 indicating that McKesson is being referred to more favorably in the media.
85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.2% of McKesson shares are held by insiders. Comparatively, 15.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
McKesson has a net margin of 0.97% compared to McKesson's net margin of 0.67%. McKesson's return on equity of 268.67% beat Cencora's return on equity.
McKesson pays an annual dividend of $2.48 per share and has a dividend yield of 0.4%. Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. McKesson pays out 11.1% of its earnings in the form of a dividend. Cencora pays out 22.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has raised its dividend for 16 consecutive years and Cencora has raised its dividend for 14 consecutive years.
McKesson received 214 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.16% of users gave McKesson an outperform vote while only 65.12% of users gave Cencora an outperform vote.
Summary
McKesson beats Cencora on 15 of the 21 factors compared between the two stocks.
Get Cencora News Delivered to You Automatically
Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
